Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
Links shared publicly online about this topic.
- 1,228total visits
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.
View full resource at online.wsj.com
Tags: Cancer, Breast Cancer, Osteoporosis Medication, Drug, Women's Health, Evista
Most Recently Shared on April 20, 2010 at 1:08 am By:
Older Drug Cuts Cancer Risk More http://on.wsj.com/clwmfv
Advertisement
